Dinh:Thesis Overview: Difference between revisions

From ZhangLabWiki
Jump to navigation Jump to search
>Dinh
(Created page with "===Samples: Data analysis === * ''' Salk's Human Tissues Whole Genome Bisulfite Sequencing '''' ** Paper: Not out yet * ''' Human peripheral mononuclear cells trio - type 2 di...")
 
>Dinh
mNo edit summary
Line 9: Line 9:
===Samples: Data generation ===  
===Samples: Data generation ===  
* ''' Early definitive endoderm differentiation (Song's 3-days protocol)'''
* ''' Early definitive endoderm differentiation (Song's 3-days protocol)'''
** {| class="wikitable"
| align="center" style="background:#f0f0f0;"|'''Tube ID'''
| align="center" style="background:#f0f0f0;"|'''Sample'''
| align="center" style="background:#f0f0f0;"|'''Concentration (QUBIT, ng/ul)'''
|-
| MA-16||H1 p54 Control TeSR||57.0
|-
| MA-17||H1 p54 Activin-A||40.1
|-
| AP-13||H1 p47 Control TeSR||85.0
|-
| AP-14||H1 p47 BMP-4||49.4
|-
| ESCd0.1||Day 0 ESCs||40.3
|-
| ESCd0.2||Day 0 ESCs||56.0
|-
| ESCd0.3||Day 0 ESCs||86.0
|-
| DE-d3.1||Day 3 definitive endoderm||34.0
|-
| DE-d3.2||Day 3 definitive endoderm||37.7
|-
| DE-d3.3||Day 3 definitive endoderm||25.7
|-
| NaiveESC.1||naïve ESCs cells||26.3
|-
| NaiveESC.2||naïve ESCs cells||30.0
|}
* ''' 10 MDS patients, known genotypes, (w/ Tiffany from Dr. Bejar's Lab)'''
* ''' 10 MDS patients, known genotypes, (w/ Tiffany from Dr. Bejar's Lab)'''
* ''' K562 cell lines: TET2 knockout (2), DNMT3a knockout (2), wildtype (2), (w/ Tiffany from Dr. Bejar's Lab)'''
* ''' K562 cell lines: TET2 knockout (2), DNMT3a knockout (2), wildtype (2), (w/ Tiffany from Dr. Bejar's Lab)'''

Revision as of 17:03, 13 March 2015

Samples: Data analysis

Samples: Data generation

  • Early definitive endoderm differentiation (Song's 3-days protocol)
    • {| class="wikitable"

| align="center" style="background:#f0f0f0;"|Tube ID | align="center" style="background:#f0f0f0;"|Sample | align="center" style="background:#f0f0f0;"|Concentration (QUBIT, ng/ul) |- | MA-16||H1 p54 Control TeSR||57.0 |- | MA-17||H1 p54 Activin-A||40.1 |- | AP-13||H1 p47 Control TeSR||85.0 |- | AP-14||H1 p47 BMP-4||49.4 |- | ESCd0.1||Day 0 ESCs||40.3 |- | ESCd0.2||Day 0 ESCs||56.0 |- | ESCd0.3||Day 0 ESCs||86.0 |- | DE-d3.1||Day 3 definitive endoderm||34.0 |- | DE-d3.2||Day 3 definitive endoderm||37.7 |- | DE-d3.3||Day 3 definitive endoderm||25.7 |- | NaiveESC.1||naïve ESCs cells||26.3 |- | NaiveESC.2||naïve ESCs cells||30.0 |}

  • 10 MDS patients, known genotypes, (w/ Tiffany from Dr. Bejar's Lab)
  • K562 cell lines: TET2 knockout (2), DNMT3a knockout (2), wildtype (2), (w/ Tiffany from Dr. Bejar's Lab)